InvestorsHub Logo
icon url

john1045

03/05/13 1:22 PM

#7100 RE: montanus #7099

Montanus...I agree as I have a bunch of shares and bought more when it went below $.02. The risk is worth the reward and with ViroPharma and Lonza involved with Intellect this could be the year for ILNS! Just need to be patient and wait for Pfizer litigation to conclude and balance of year more progression of results from these players will push the PPS much higher. ILNS market cap is a really way undervalued when you look at ViroPharma and Lonza royalty potential alone! JMHO!
icon url

itwillgetbetter

03/05/13 1:30 PM

#7102 RE: montanus #7099

Opened the door to go to lunch.What is on the door mat a black cat!

Not superstitious really but it made me think about it.


I have no real clue how much lower it can or will go.I own what I do and have no intent to sale.Consider them locked up until major events occur.


Just makes no sense to issue a pr stating how undervalued the pps is and not be willing to back it up by making a serious statement.

No doubt if the officers bought the common it would appreciate its value.